The first glimpse of the full-length KAR structure was a relatively low-resolution, 7.6- reconstruction of homomeric GluK2 in the high-affinity agonist (2S, 4R)-4-methylglutamate (SYM 2081)-bound non-conducting state (Meyerson et al., 2014), which was followed by a similar successor structure with improved 3.8- resolution (Meyerson et al., 2016)
Certain metabolic disorders
Medical history, contraindications, financial considerations, adherence capacity, and personal preferences all influence treatment selection
Its interaction with the nitric oxide system is of particular interest, as this pathway contributes to vascular stability, cellular communication, and adaptive tissue responses in regenerative research models